SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009746
Filing Date
2022-05-12
Accepted
2022-05-12 16:59:12
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ymtx-20220331.htm   iXBRL 10-Q 2697384
2 EX-10.3 ymtx-ex10_3.htm EX-10.3 82264
3 EX-10.4 ymtx-ex10_4.htm EX-10.4 117219
4 EX-31.1 ymtx-ex31_1.htm EX-31.1 21341
5 EX-31.2 ymtx-ex31_2.htm EX-31.2 21409
6 EX-32.1 ymtx-ex32_1.htm EX-32.1 25740
  Complete submission text file 0000950170-22-009746.txt   9592717

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ymtx-20220331_def.xml EX-101.DEF 240956
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ymtx-20220331_pre.xml EX-101.PRE 374980
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ymtx-20220331_lab.xml EX-101.LAB 525808
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ymtx-20220331_cal.xml EX-101.CAL 60921
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ymtx-20220331.xsd EX-101.SCH 60855
63 EXTRACTED XBRL INSTANCE DOCUMENT ymtx-20220331_htm.xml XML 1650160
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 22918764
SIC: 2834 Pharmaceutical Preparations